CALLIDITAS THERAPEUTICS

calliditas-therapeutics-logo

Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which Calliditas can partially or completely participate in the commercialization efforts. Calliditas is focused on the development and commercialization of the product candidate Nefecon, a unique two step formulation optimized to combine a time lag effect with a co... ncentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy (IgAN). Calliditas is running a global Phase 3 study within IgAN and aims to commercialize Nefecon in the United States.

#SimilarOrganizations #People #Financial #Event #Website #More

CALLIDITAS THERAPEUTICS

Industry:
Biotechnology Medical Device Pharmaceutical

Founded:
1991-01-01

Address:
Stockholm, Stockholms Lan, Sweden

Country:
Sweden

Website Url:
http://www.calliditas.se

Total Employee:
51+

Status:
Active

Contact:
(468)411-3005

Email Addresses:
[email protected]

Total Funding:
108.2 M USD

Technology used in webpage:
Google Maps Google Maps API Cloudmore


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

catalyst-biosciences-logo

Catalyst Biosciences

Catalyst Biosciences is a drug r and d company creating catalytic biopharmaceutical products based on engineered human proteases.

immutep-logo

Immutep

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

palisade-bio-logo

Palisade Bio

Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.

sirnaomics-logo

Sirnaomics

Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.


Current Advisors List

ann-tove-kongsnes_image

Ann-Tove Kongsnes Board Member @ Calliditas Therapeutics
Board_member

elmar-schnee_image

Elmar Schnee Chairman Of The Board @ Calliditas Therapeutics
Board_member
2019-05-01

Current Employees Featured

fredrik-johansson_image

Fredrik Johansson
Fredrik Johansson Chief Financial Officer @ Calliditas Therapeutics
Chief Financial Officer
2017-08-01

bengt-julander_image

Bengt Julander
Bengt Julander founder @ Calliditas Therapeutics
founder

not_available_image

Mikael Bender
Mikael Bender Co-Founder @ Calliditas Therapeutics
Co-Founder

richard-philipson_image

Richard Philipson
Richard Philipson Chief Medical Officer @ Calliditas Therapeutics
Chief Medical Officer
2020-06-01

marek-poszepczynski_image

Marek Poszepczynski
Marek Poszepczynski Business Development Director @ Calliditas Therapeutics
Business Development Director

renee-aguiar-lucander_image

Renee Aguiar-Lucander
Renee Aguiar-Lucander Chief Executive Officer @ Calliditas Therapeutics
Chief Executive Officer
2017-04-01

johan-häggblad_image

Johan Häggblad
Johan Häggblad Managing Director @ Calliditas Therapeutics
Managing Director

Founder


bengt-julander_image

Bengt Julander

not_available_image

Mikael Bender

Stock Details


Company's stock symbol is NASDAQ:CALT

Acquisitions List

Date Company Article Price
2020-08-13 Genkyotex Genkyotex acquired by Calliditas Therapeutics 20.3 M USD

Investors List

kreos-capital_image

Kreos Capital

Kreos Capital investment in Debt Financing - Calliditas Therapeutics

industrifonden_image

Industrifonden

Industrifonden investment in Series C - Calliditas Therapeutics

industrifonden_image

Industrifonden

Industrifonden investment in Venture Round - Calliditas Therapeutics

Key Employee Changes

Date New article
2020-04-06 Calliditas appoints new Chief Medical Officer

Official Site Inspections

http://www.calliditas.se Semrush global rank: 2.37 M Semrush visits lastest month: 7.8 K

  • Host name: 104.18.23.112
  • IP address: 104.18.23.112
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Calliditas Therapeutics"

Calliditas strengthens its US Commercial Organization

Renée Aguiar-Lucander, CEO, Calliditas Email: [email protected] Telephone: +46 722 52 10 06 Mikael Widell, Head of Communications Email: [email protected]See details»

About Us – Calliditas Therapeutics AB

Calliditas is dedicated to expanding treatment options and establishing new standards of care for people with rare diseases. By drawing on our expertise in pharmaceutical product …See details»

Calliditas Therapeutics - Crunchbase Company Profile …

Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical …See details»

About the website – Calliditas Therapeutics AB

Calliditas is a commercial stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and …See details»

Calliditas Therapeutics | LinkedIn

Calliditas Therapeutics | 12 091 följare på LinkedIn. Pioneering treatments for rare diseases. We harness scientific & commercial expertise to improve the lives of patients. | Calliditas …See details»

Calliditas Therapeutics – Wikipedia

Calliditas Therapeutics AB är ett svenskt, tidigare börsnoterat, läkemedelsföretag, som utvecklar läkemedel för njur- och leversjukdomar, bland andra ett specialistläkemedel mot …See details»

Calliditas Therapeutics - Overview, News & Similar companies

Jul 21, 2024 Notice of extraordinary meeting of Calliditas Therapeutics AB (publ) The shareholders of Calliditas Therapeutics AB (publ) (“Calliditas Therapeutics”), Reg. No. 556659 …See details»

Full List of Biotech Companies in Geneva (2025)

Feb 8, 2025 Geneva is also home to key global health institutions such as the Red Cross and the World Health Organization. Other important non-profit research institutions like Drugs for …See details»

Calliditas Therapeutics AB - Kungsbron 1, Stockholm - Hitta.se

Calliditas Therapeutics AB gick med förlust (2023) Calliditas Therapeutics AB gick med förlust, -273 518 000 kr. Calliditas Therapeutics AB ökade sin omsättning med 43,54% senaste …See details»

Associate Director/Director, US Thought Leader Liaison (TX/LA)

Calliditas, an ambitious pharmaceutical company is growing! To match our exciting growth plans we're looking for new employees to join our journey. ... Strong strategic and tactical planning, …See details»

Calliditas Therapeutics - Contacts, Employees, Board Members, …

Organization. Calliditas Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 7. Number of …See details»

Om Calliditas Therapeutics AB - Hitta.se

Hitta information om Calliditas Therapeutics AB. Företaget gick med förlust år 2023, omsättning 1 025 844 tkr. Telefon: 070-535 07 ..See details»

Calliditas Therapeutics : strengthens its US Commercial and …

Mar 8, 2021 Calliditas Therapeutics AB today announced the appointment of three industry veterans: Warren Brooks, PhD, as Vice President of US Medical Affairs, Teona Johnson as …See details»

Calliditas Therapeutics - Cision News

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) meddelar idag att årsredovisningen för 2023 nu finns tillgänglig på bolagets hemsida www.calliditas.se. För mer …See details»

Calliditas Therapeutics AB - Cruelty Free Investing

Calliditas Therapeutics AB, formerly Pharmalink AB, is a Sweden-based specialty pharmaceutical company. It is focused on the development and commercialization of its product candidate …See details»

Career at Calliditas - Calliditas Therapeutics

Calliditas Therapeutics and our selected partners use cookies and similar technologies (together “cookies”) that are necessary to present this website, and to ensure you get the best …See details»

MFN.se > Calliditas Therapeutics > Statement by the Board of …

May 28, 2024 Background This statement is made by the Board of Directors (the "Board") of Calliditas Therapeutics AB (publ) ("Calliditas" or the "Company") pursuant to section II.19 of …See details»

Kallelse till extra bolagsstämma i Calliditas Therapeutics AB (publ)

Anmäla sig per post till Calliditas Therapeutics AB (publ), Extra Bolagsstämma 2024, c/o Euroclear Sweden, Box 191, 101 23 Stockholm eller via e-post till . …See details»

Calliditas Therapeutics AB (Calliditas Therapeutics AB) - 药物管线_ …

了解Calliditas Therapeutics AB (Calliditas Therapeutics AB)公司的药物管线,治疗领域,技术平台,以及它的20项临床试验, 222篇新闻,疾病领域:血液及淋巴系统疾病,肿瘤,免疫系统疾 …See details»

Calliditas Aktie 2025 - CALTX - Webbinvestor.se

Fördelar med att investera i Calliditas Aktie. 1. Innovativ produktportfölj: Calliditas erbjuder innovativa läkemedelsprodukter inom områden som njursjukdomar och leveråkommor. 2. …See details»

linkstock.net © 2022. All rights reserved